INM SCHEDULE 13G/A: SEC filing

Squadron Capital Management LLC and related entities

Filed with the SEC on · accession 0002050709-26-000034

INM filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Squadron Capital Management LLC and related entities filed an amended Schedule 13G indicating they no longer beneficially own any shares of InMed Pharmaceuticals, a decrease from their prior position.

Key details

shares beneficially owned$0
percent of class owned$0
Filer / former beneficial ownerSquadron Capital Management LLC
Filer / former beneficial ownerSquadron Master Fund LP
IssuerInMed Pharmaceuticals Inc.
Partner, squadron capital management llcMatthew Sesterhenn
Authorized signatoryWilliam Blank

✦ Ask GOAX AI about this filing — what it means for INM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for INM?

Click here

Frequently asked questions

What did INM file with the SEC on Nov 16, 2026?

INM filed a SCHEDULE 13G/A (SEC filing). Squadron Capital Management LLC and related entities filed an amended Schedule 13G indicating they no longer beneficially own any shares of InMed Pharmaceuticals, a decrease from their prior position.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other INM SEC filings

Get alerts when INM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days